BioRestorative Therapies issues Q2 2025 earnings; no figures in provided excerpt

BioRestorative Therapies, Inc.

2025-Q2 EPS reported -$0.94 revenue$328,300

Press release dated Aug 12, 2025 announces Q2 financial results and a business update.
Conference call scheduled to discuss the results; details in the press release.
Specific revenue, EPS, and segment data not included in the filing text provided.

item 2.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.